NCT07575425 Effects of Mobilized Balance Platform Exercises on Balance Parameters in Patients With Knee Osteoarthritis
| NCT ID | NCT07575425 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Gaziler Physical Medicine and Rehabilitation Education and Research Hospital |
| Condition | Osteearthritis |
| Study Type | INTERVENTIONAL |
| Enrollment | 36 participants |
| Start Date | 2026-05-04 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 36 participants in total. It began in 2026-05-04 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective single-blind randomized controlled study aims to investigate the effects of mobilized balance platform exercises on balance parameters, pain, functional status, fear of falling, and kinesiophobia in patients with knee osteoarthritis. A total of 36 patients diagnosed with knee osteoarthritis will be recruited from the outpatient clinic of Gaziler Physical Medicine and Rehabilitation Training and Research Hospital. Participants will be randomly assigned to one of two groups. The control group will receive conventional physical therapy including transcutaneous electrical nerve stimulation (TENS) and a home exercise program consisting of knee strengthening, balance, range of motion, proprioceptive, and stretching exercises. The intervention group will receive the same conventional treatment in addition to mobilized balance platform exercises using the Huber 360 system. Pain severity, functional status, balance parameters, fear of falling, and kinesiophobia will be evaluated before and after treatment by an assessor blinded to treatment allocation.
Eligibility Criteria
Inclusion Criteria: * Patients aged between 45 and 65 years * Diagnosis of knee osteoarthritis classified as Kellgren-Lawrence grade 2 or 3 * Willingness to participate voluntarily in the study Exclusion Criteria: * Presence of orthopedic knee implants * Kellgren-Lawrence grade 1 or grade 4 knee osteoarthritis * Sensory impairment * Diagnosis of malignancy * Unhealed fractures * Circulatory disorders * Infection around the knee joint * Severe hearing loss or visual impairment * Cognitive impairment * Uncontrolled hypertension or diabetes mellitus * Vestibular disorders causing balance problems, such as vertigo * Use of walking assistive devices such as canes or walkers
Contact & Investigator
Sefa Gümrük Aslan
PRINCIPAL INVESTIGATOR
gaziler physcial therapy and rehabilitation hospital
Frequently Asked Questions
Who can join the NCT07575425 clinical trial?
This trial is open to participants of all sexes, aged 45 Years or older, up to 65 Years, studying Osteearthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07575425 currently recruiting?
Yes, NCT07575425 is actively recruiting participants. Contact the research team at sefagumrukk@gmail.com for enrollment information.
Where is the NCT07575425 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07575425 clinical trial?
NCT07575425 is sponsored by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital. The principal investigator is Sefa Gümrük Aslan at gaziler physcial therapy and rehabilitation hospital. The trial plans to enroll 36 participants.